Storage of platelets at 4°C in platelet additive solutions prevents aggregate formation and preserves platelet functional responses

Transfusion

Volumn 56, Issue 6, 2016, Pages 1320-1328

  Getz, Todd M ^a   Montgomery, Robbie K ^a   Bynum, James A ^a   Aden, James K ^a   Pidcoke, Heather F ^a   Cap, Andrew P ^a  

^a US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; FIBRINOGEN; FIBRINOGEN RECEPTOR; INTEGRIN; SOLUTION AND SOLUBILITY;

ARTICLE; BLOOD GAS; BLOOD SAMPLING; CALCIUM CELL LEVEL; CONTROLLED STUDY; DILUTION; FIBRINOGEN BLOOD LEVEL; FLOW CYTOMETRY; HUMAN; HUMAN EXPERIMENT; MEASUREMENT; NORMAL HUMAN; PLASMA; PLASMAPHERESIS; PLATELET ADDITIVE SOLUTION; PLATELET MICROPARTICLE; PROTEIN BINDING; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE PRESERVATION; THROMBOCYTOPHERESIS; BLOOD STORAGE; CRYOPRESERVATION; DRUG EFFECTS; METABOLISM; PHARMACOLOGY; PROCEDURES; REFRIGERATION; SOLUTION AND SOLUBILITY;

BLOOD PRESERVATION; CRYOPRESERVATION; HUMANS; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELETPHERESIS; REFRIGERATION; SOLUTIONS;

EID: 84958817419     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13511     Document Type: Article

References (39)

1. Perkins JG, Cap AP, Spinella PC, et al., An evaluation of the impact of apheresis platelets used in the setting of massively transfused trauma patients. J Trauma 2009; 66: S77-84; discussion S-5.
2. Spinella PC., Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications. Crit Care Med 2008; 36: S340-5.
3. Stroncek DF, Rebulla P., Platelet transfusions. Lancet 2007; 370: 427-38.
4. Whitaker BI, Henrt RA., The 2011 national blood collection and utilization survey report. Rockville (MD): US Department of Health and Human Services; 2013.
5. FDA. CFR Code of Federal Regulations Title 21 Revised April 1, 2015;7.
6. Currie LM, Harper JR, Allan H, et al., Inhibition of cytokine accumulation and bacterial growth during storage of platelet concentrates at 4 degrees C with retention of in vitro functional activity. Transfusion 1997; 37: 18-24.
7. Hoffmeister KM, Falet H, Toker A, et al., Mechanisms of cold-induced platelet actin assembly. J Biol Chem 2001; 276: 24751-9.
8. Oliver AE, Tablin F, Walker NJ, et al., The internal calcium concentration of human platelets increases during chilling. Biochim Biophys Acta 1999; 1416: 349-60.
9. White JG., The substructure of human platelet microtubules. Blood 1968; 32: 638-48.
10. Winokur R, Hartwig JH., Mechanism of shape change in chilled human platelets. Blood 1995; 85: 1796-804.
11. Kattlove HE, Alexander B., The effect of cold on platelets. I. Cold-induced platelet aggregation. Blood 1971; 38: 39-48.
12. Babic AM, Josefsson EC, Bergmeier W, et al., In vitro function and phagocytosis of galactosylated platelet concentrates after long-term refrigeration. Transfusion 2007; 47: 442-51.
13. Choi JW, Pai SH., Influence of storage temperature on the responsiveness of human platelets to agonists. Ann Clin Lab Sci 2003; 33: 79-85.
14. Nair PM, Pidcoke HF, Cap AP, et al., Effect of cold storage on shear-induced platelet aggregation and clot strength. J Trauma Acute Care Surg 2014; 77: S88-93.
15. Reddoch KM, Pidcoke HF, Montgomery RK, et al., Hemostatic function of apheresis platelets stored at 4°C and 22°C. Shock 2014; 41: 54-61.
16. Becker GA, Tuccelli M, Kunicki T, et al., Studies of platelet concentrates stored at 22 C and 4 C. Transfusion 1973; 13: 61-8.
17. Manno CS, Hedberg KW, Kim HC, et al., Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children. Blood 1991; 77: 930-6.
18. Murphy S, Gardner FH., The effect of temperature on platelet viability. Vox Sang 1969; 17: 22.
19. Alhumaidan H, Sweeney J., Current status of additive solutions for platelets. J Clin Apher 2012; 27: 93-8.
20. Ringwald J, Haager B, Krex D, et al., Impact of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets. Transfusion 2006; 46: 942-8.
21. Adams GA, Swenson SD, Rock G., Survival and recovery of human platelets stored for five days in a non-plasma medium. Blood 1986; 67: 672-5.
22. Gulliksson H, AuBuchon JP, Vesterinen M, et al., Storage of platelets in additive solutions: a pilot in vitro study of the effects of potassium and magnesium. Vox Sang 2002; 82: 131-6.
23. Holme S, Heaton WA, Courtright M., Improved in vivo and in vitro viability of platelet concentrates stored for seven days in a platelet additive solution. Br J Haematol 1987; 66: 233-8.
24. Vassallo RR, Adamson JW, Gottschall JL, et al., In vitro and in vivo evaluation of apheresis platelets stored for 5 days in 65% platelet additive solution/35% plasma. Transfusion 2010; 50: 2376-85.
25. Clauss A., Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957; 17: 237-46.
26. Bertolini F, Murphy S, Rebulla P, et al., Role of acetate during platelet storage in a synthetic medium. Transfusion 1992; 32: 152-6.
27. Sandgren P, Shanwell A, Gulliksson H., Storage of buffy coat-derived platelets in additive solutions: in vitro effects of storage at 4 degrees C. Transfusion 2006; 46: 828-34.
28. Sandgren P, Hansson M, Gulliksson H, et al., Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression. Vox Sang 2007; 93: 27-36.
29. Jansen AJ, Josefsson EC, Rumjantseva V, et al., Desialylation accelerates platelet clearance after refrigeration and initiates GPIbα metalloproteinase-mediated cleavage in mice. Blood 2012; 119: 1263-73.
30. DiMinno G, Silver MJ, Murphy S., Stored human platelets retain full aggregation potential in response to pairs of aggregating agents. Blood 1982; 59: 563-8.
31. Rock G, Figueredo A., Metabolic changes during platelet storage. Transfusion 1976; 16: 571-9.
32. Razmara M, Hu H, Masquelier M, et al., Glycoprotein IIb/IIIa blockade inhibits platelet aminophospholipid exposure by potentiating translocase and attenuating scramblase activity. Cell Mol Life Sci 2007; 64: 999-1008.
33. Shimizu T, Murphy S., Roles of acetate and phosphate in the successful storage of platelet concentrates prepared with an acetate-containing additive solution. Transfusion 1993; 33: 304-10.
34. Valeri CR., Circulation and hemostatic effectiveness of platelets stored at 4 C or 22 C: studies in aspirin-treated normal volunteers. Transfusion 1976; 16: 20-3.
35. Murphy EA, Francis ME., The estimation of blood platelet survival. I. General principles of the study of cell survival. Thromb Diath Haemorrh 1969; 22: 281-95.
36. Barn K, Steinhubl SR., A brief review of the past and future of platelet P2Y12 antagonist. Coron Artery Dis 2012; 23: 368-74.
37. Getz TM, Piatt R, Petrich BG, et al., Novel mouse hemostasis model for real-time determination of bleeding time and hemostatic plug composition. J Thromb Haemost 2015; 13: 417-25.
38. Nicholas RA., Identification of the P2Y(12) receptor: a novel member of the P2Y family of receptors activated by extracellular nucleotides. Mol Pharmacol 2001; 60: 416-20.
39. Stalker TJ, Traxler EA, Wu J, et al., Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network. Blood 2013; 121: 1875-85.